ID   KPCI_RAT                Reviewed;         596 AA.
AC   F1M7Y5; B1PZT8;
DT   14-DEC-2011, integrated into UniProtKB/Swiss-Prot.
DT   03-MAY-2011, sequence version 1.
DT   02-OCT-2024, entry version 96.
DE   RecName: Full=Protein kinase C iota type;
DE            EC=2.7.11.13;
DE   AltName: Full=Atypical protein kinase C-lambda/iota;
DE            Short=aPKC-lambda/iota;
DE   AltName: Full=nPKC-iota;
GN   Name=Prkci; Synonyms=Pkcl;
OS   Rattus norvegicus (Rat).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC   Eutheria; Euarchontoglires; Glires; Rodentia; Myomorpha; Muroidea; Muridae;
OC   Murinae; Rattus.
OX   NCBI_TaxID=10116;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA], AND IDENTIFICATION.
RC   STRAIN=Brown Norway;
RX   PubMed=15057822; DOI=10.1038/nature02426;
RA   Gibbs R.A., Weinstock G.M., Metzker M.L., Muzny D.M., Sodergren E.J.,
RA   Scherer S., Scott G., Steffen D., Worley K.C., Burch P.E., Okwuonu G.,
RA   Hines S., Lewis L., Deramo C., Delgado O., Dugan-Rocha S., Miner G.,
RA   Morgan M., Hawes A., Gill R., Holt R.A., Adams M.D., Amanatides P.G.,
RA   Baden-Tillson H., Barnstead M., Chin S., Evans C.A., Ferriera S.,
RA   Fosler C., Glodek A., Gu Z., Jennings D., Kraft C.L., Nguyen T.,
RA   Pfannkoch C.M., Sitter C., Sutton G.G., Venter J.C., Woodage T., Smith D.,
RA   Lee H.-M., Gustafson E., Cahill P., Kana A., Doucette-Stamm L.,
RA   Weinstock K., Fechtel K., Weiss R.B., Dunn D.M., Green E.D.,
RA   Blakesley R.W., Bouffard G.G., De Jong P.J., Osoegawa K., Zhu B., Marra M.,
RA   Schein J., Bosdet I., Fjell C., Jones S., Krzywinski M., Mathewson C.,
RA   Siddiqui A., Wye N., McPherson J., Zhao S., Fraser C.M., Shetty J.,
RA   Shatsman S., Geer K., Chen Y., Abramzon S., Nierman W.C., Havlak P.H.,
RA   Chen R., Durbin K.J., Egan A., Ren Y., Song X.-Z., Li B., Liu Y., Qin X.,
RA   Cawley S., Cooney A.J., D'Souza L.M., Martin K., Wu J.Q.,
RA   Gonzalez-Garay M.L., Jackson A.R., Kalafus K.J., McLeod M.P.,
RA   Milosavljevic A., Virk D., Volkov A., Wheeler D.A., Zhang Z., Bailey J.A.,
RA   Eichler E.E., Tuzun E., Birney E., Mongin E., Ureta-Vidal A., Woodwark C.,
RA   Zdobnov E., Bork P., Suyama M., Torrents D., Alexandersson M., Trask B.J.,
RA   Young J.M., Huang H., Wang H., Xing H., Daniels S., Gietzen D., Schmidt J.,
RA   Stevens K., Vitt U., Wingrove J., Camara F., Mar Alba M., Abril J.F.,
RA   Guigo R., Smit A., Dubchak I., Rubin E.M., Couronne O., Poliakov A.,
RA   Huebner N., Ganten D., Goesele C., Hummel O., Kreitler T., Lee Y.-A.,
RA   Monti J., Schulz H., Zimdahl H., Himmelbauer H., Lehrach H., Jacob H.J.,
RA   Bromberg S., Gullings-Handley J., Jensen-Seaman M.I., Kwitek A.E.,
RA   Lazar J., Pasko D., Tonellato P.J., Twigger S., Ponting C.P., Duarte J.M.,
RA   Rice S., Goodstadt L., Beatson S.A., Emes R.D., Winter E.E., Webber C.,
RA   Brandt P., Nyakatura G., Adetobi M., Chiaromonte F., Elnitski L.,
RA   Eswara P., Hardison R.C., Hou M., Kolbe D., Makova K., Miller W.,
RA   Nekrutenko A., Riemer C., Schwartz S., Taylor J., Yang S., Zhang Y.,
RA   Lindpaintner K., Andrews T.D., Caccamo M., Clamp M., Clarke L., Curwen V.,
RA   Durbin R.M., Eyras E., Searle S.M., Cooper G.M., Batzoglou S., Brudno M.,
RA   Sidow A., Stone E.A., Payseur B.A., Bourque G., Lopez-Otin C., Puente X.S.,
RA   Chakrabarti K., Chatterji S., Dewey C., Pachter L., Bray N., Yap V.B.,
RA   Caspi A., Tesler G., Pevzner P.A., Haussler D., Roskin K.M., Baertsch R.,
RA   Clawson H., Furey T.S., Hinrichs A.S., Karolchik D., Kent W.J.,
RA   Rosenbloom K.R., Trumbower H., Weirauch M., Cooper D.N., Stenson P.D.,
RA   Ma B., Brent M., Arumugam M., Shteynberg D., Copley R.R., Taylor M.S.,
RA   Riethman H., Mudunuri U., Peterson J., Guyer M., Felsenfeld A., Old S.,
RA   Mockrin S., Collins F.S.;
RT   "Genome sequence of the Brown Norway rat yields insights into mammalian
RT   evolution.";
RL   Nature 428:493-521(2004).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [MRNA] OF 10-596.
RC   STRAIN=Wistar;
RX   PubMed=19090727; DOI=10.1515/bc.2009.031;
RA   Stross C., Keitel V., Winands E., Haussinger D., Kubitz R.;
RT   "Expression and localization of atypical PKC isoforms in liver parenchymal
RT   cells.";
RL   Biol. Chem. 390:235-244(2009).
RN   [3]
RP   SUBCELLULAR LOCATION, PHOSPHORYLATION AT TYR-265, AND MUTAGENESIS OF
RP   TYR-265.
RX   PubMed=11891849; DOI=10.1002/jcb.10101.abs;
RA   White W.O., Seibenhener M.L., Wooten M.W.;
RT   "Phosphorylation of tyrosine 256 facilitates nuclear import of atypical
RT   protein kinase C.";
RL   J. Cell. Biochem. 85:42-53(2002).
RN   [4]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT THR-564, AND IDENTIFICATION BY
RP   MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=22673903; DOI=10.1038/ncomms1871;
RA   Lundby A., Secher A., Lage K., Nordsborg N.B., Dmytriyev A., Lundby C.,
RA   Olsen J.V.;
RT   "Quantitative maps of protein phosphorylation sites across 14 different rat
RT   organs and tissues.";
RL   Nat. Commun. 3:876-876(2012).
RN   [5]
RP   FUNCTION, TISSUE SPECIFICITY, PHOSPHORYLATION AT THR-564, AND DISRUPTION
RP   PHENOTYPE.
RX   PubMed=27498875; DOI=10.1016/j.celrep.2016.07.030;
RA   Wang S., Sheng T., Ren S., Tian T., Lu W.;
RT   "Distinct Roles of PKCiota/lambda and PKMzeta in the Initiation and
RT   Maintenance of Hippocampal Long-Term Potentiation and Memory.";
RL   Cell Rep. 16:1954-1961(2016).
CC   -!- FUNCTION: Calcium- and diacylglycerol-independent serine/ threonine-
CC       protein kinase that plays a general protective role against apoptotic
CC       stimuli, is involved in NF-kappa-B activation, cell survival,
CC       differentiation and polarity, and contributes to the regulation of
CC       microtubule dynamics in the early secretory pathway. Is necessary for
CC       BCR-ABL oncogene-mediated resistance to apoptotic drug in leukemia
CC       cells, protecting leukemia cells against drug-induced apoptosis. In
CC       cultured neurons, prevents amyloid beta protein-induced apoptosis by
CC       interrupting cell death process at a very early step. In glioblastoma
CC       cells, may function downstream of phosphatidylinositol 3-kinase (PI3K)
CC       and PDPK1 in the promotion of cell survival by phosphorylating and
CC       inhibiting the pro-apoptotic factor BAD. Can form a protein complex in
CC       non-small cell lung cancer (NSCLC) cells with PARD6A and ECT2 and
CC       regulate ECT2 oncogenic activity by phosphorylation, which in turn
CC       promotes transformed growth and invasion. In response to nerve growth
CC       factor (NGF), acts downstream of SRC to phosphorylate and activate
CC       IRAK1, allowing the subsequent activation of NF-kappa-B and neuronal
CC       cell survival. Functions in the organization of the apical domain in
CC       epithelial cells by phosphorylating EZR. This step is crucial for
CC       activation and normal distribution of EZR at the early stages of
CC       intestinal epithelial cell differentiation. Forms a protein complex
CC       with LLGL1 and PARD6B independently of PARD3 to regulate epithelial
CC       cell polarity. Plays a role in microtubule dynamics in the early
CC       secretory pathway through interaction with RAB2A and GAPDH and
CC       recruitment to vesicular tubular clusters (VTCs). In human coronary
CC       artery endothelial cells (HCAEC), is activated by saturated fatty acids
CC       and mediates lipid-induced apoptosis. Downstream of PI3K is required
CC       for insulin-stimulated glucose transport. Activates RAB4A and promotes
CC       its association with KIF3A which is required for the insulin-induced
CC       SLC2A4/GLUT4 translocation in adipocytes. Is essential in early
CC       embryogenesis and development of differentiating photoreceptors by
CC       playing a role in the establishment of epithelial and neuronal polarity
CC       (By similarity). Involved in early synaptic long term potentiation
CC       phase in CA1 hippocampal cells and short term memory formation
CC       (PubMed:27498875). {ECO:0000250, ECO:0000269|PubMed:27498875}.
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=ATP + L-seryl-[protein] = ADP + H(+) + O-phospho-L-seryl-
CC         [protein]; Xref=Rhea:RHEA:17989, Rhea:RHEA-COMP:9863, Rhea:RHEA-
CC         COMP:11604, ChEBI:CHEBI:15378, ChEBI:CHEBI:29999, ChEBI:CHEBI:30616,
CC         ChEBI:CHEBI:83421, ChEBI:CHEBI:456216; EC=2.7.11.13;
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=ATP + L-threonyl-[protein] = ADP + H(+) + O-phospho-L-
CC         threonyl-[protein]; Xref=Rhea:RHEA:46608, Rhea:RHEA-COMP:11060,
CC         Rhea:RHEA-COMP:11605, ChEBI:CHEBI:15378, ChEBI:CHEBI:30013,
CC         ChEBI:CHEBI:30616, ChEBI:CHEBI:61977, ChEBI:CHEBI:456216;
CC         EC=2.7.11.13;
CC   -!- ACTIVITY REGULATION: Atypical PKCs (PRKCI and PRKCZ) exhibit an
CC       elevated basal enzymatic activity (that may be due to the interaction
CC       with SMG1 or SQSTM1) and are not regulated by diacylglycerol,
CC       phosphatidylserine, phorbol esters or calcium ions. Two specific sites,
CC       Thr-412 (activation loop of the kinase domain) and Thr-564 (turn
CC       motif), need to be phosphorylated for its full activation. Might also
CC       be a target for novel lipid activators that are elevated during
CC       nutrient-stimulated insulin secretion (By similarity). {ECO:0000250}.
CC   -!- SUBUNIT: Forms a complex with SQSTM1 and MP2K5 (By similarity).
CC       Interacts directly with SQSTM1 (Probable). Interacts with IKBKB.
CC       Interacts with PARD6A, PARD6B and PARD6G. Part of a quaternary complex
CC       containing aPKC, PARD3, a PARD6 protein (PARD6A, PARD6B or PARD6G) and
CC       a GTPase protein (CDC42 or RAC1). Part of a complex with LLGL1 and
CC       PARD6B. Interacts with ADAP1/CENTA1. Interaction with SMG1, through the
CC       ZN-finger domain, activates the kinase activity. Interacts with CDK7.
CC       Forms a complex with RAB2A and GAPDH involved in recruitment onto the
CC       membrane of vesicular tubular clusters (VTCs). Interacts with ECT2
CC       ('Thr-359' phosphorylated form). Interacts with VAMP2. Interacts with
CC       WDFY2 (via WD repeats 1-3) (By similarity).
CC       {ECO:0000250|UniProtKB:P41743, ECO:0000305}.
CC   -!- INTERACTION:
CC       F1M7Y5; Q62824: Exoc4; NbExp=2; IntAct=EBI-8795211, EBI-6959516;
CC   -!- SUBCELLULAR LOCATION: Cytoplasm {ECO:0000269|PubMed:11891849}. Membrane
CC       {ECO:0000250|UniProtKB:P41743}. Endosome
CC       {ECO:0000250|UniProtKB:P41743}. Nucleus {ECO:0000269|PubMed:11891849}.
CC       Note=Transported into the endosome through interaction with SQSTM1/p62.
CC       After phosphorylation by SRC, transported into the nucleus through
CC       interaction with KPNB1. Colocalizes with CDK7 in the cytoplasm and
CC       nucleus. Transported to vesicular tubular clusters (VTCs) through
CC       interaction with RAB2A. {ECO:0000250|UniProtKB:P41743}.
CC   -!- TISSUE SPECIFICITY: Expressed in dorsal hippocampus (at protein level).
CC       {ECO:0000269|PubMed:27498875}.
CC   -!- DOMAIN: The PB1 domain mediates interaction with SQSTM1. {ECO:0000250}.
CC   -!- DOMAIN: The C1 zinc finger does not bind diacylglycerol (DAG).
CC       {ECO:0000250}.
CC   -!- DOMAIN: The pseudosubstrate motif resembles the sequence around sites
CC       phosphorylated on target proteins, except the presence of a non-
CC       phosphorylatable residue in place of Ser, it modulates activity by
CC       competing with substrates. {ECO:0000250}.
CC   -!- PTM: Phosphorylation at Thr-412 in the activation loop is not mandatory
CC       for activation (By similarity). Upon neuronal growth factor (NGF)
CC       stimulation, phosphorylated by SRC at Tyr-265, Tyr-280 and Tyr-334 (By
CC       similarity). Phosphorylation at Tyr-265 facilitates binding to
CC       KPNB1/importin-beta regulating entry of PRKCI into the nucleus
CC       (PubMed:11891849). Phosphorylation on Tyr-334 is important for NF-
CC       kappa-B stimulation (By similarity). Phosphorylated at Thr-564 during
CC       the initial phase of long term potentiation (PubMed:27498875).
CC       {ECO:0000250|UniProtKB:P41743, ECO:0000250|UniProtKB:Q62074,
CC       ECO:0000269|PubMed:11891849, ECO:0000269|PubMed:27498875}.
CC   -!- DISRUPTION PHENOTYPE: RNAi-mediated knockdown in the dorsal hippocampus
CC       impairs the early phase of long-term potentiation and the formation of
CC       short term memory. {ECO:0000269|PubMed:27498875}.
CC   -!- SIMILARITY: Belongs to the protein kinase superfamily. AGC Ser/Thr
CC       protein kinase family. PKC subfamily. {ECO:0000305}.
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; EU517502; ACA66272.1; -; mRNA.
DR   RefSeq; NP_114448.1; NM_032059.1.
DR   AlphaFoldDB; F1M7Y5; -.
DR   SMR; F1M7Y5; -.
DR   BioGRID; 249872; 4.
DR   CORUM; F1M7Y5; -.
DR   IntAct; F1M7Y5; 3.
DR   MINT; F1M7Y5; -.
DR   STRING; 10116.ENSRNOP00000012924; -.
DR   iPTMnet; F1M7Y5; -.
DR   PhosphoSitePlus; F1M7Y5; -.
DR   jPOST; F1M7Y5; -.
DR   PaxDb; 10116-ENSRNOP00000012924; -.
DR   Ensembl; ENSRNOT00000012924.6; ENSRNOP00000012924.4; ENSRNOG00000009652.6.
DR   Ensembl; ENSRNOT00055016309; ENSRNOP00055013108; ENSRNOG00055009646.
DR   Ensembl; ENSRNOT00060003519; ENSRNOP00060002411; ENSRNOG00060002248.
DR   Ensembl; ENSRNOT00065041525; ENSRNOP00065033924; ENSRNOG00065024212.
DR   GeneID; 84006; -.
DR   KEGG; rno:84006; -.
DR   UCSC; RGD:620961; rat.
DR   AGR; RGD:620961; -.
DR   CTD; 5584; -.
DR   RGD; 620961; Prkci.
DR   eggNOG; KOG0695; Eukaryota.
DR   GeneTree; ENSGT00940000153497; -.
DR   HOGENOM; CLU_000288_63_29_1; -.
DR   InParanoid; F1M7Y5; -.
DR   OMA; FIDWEAL; -.
DR   OrthoDB; 841660at2759; -.
DR   TreeFam; TF102004; -.
DR   Reactome; R-RNO-1912408; Pre-NOTCH Transcription and Translation.
DR   Reactome; R-RNO-209543; p75NTR recruits signalling complexes.
DR   Reactome; R-RNO-420029; Tight junction interactions.
DR   Reactome; R-RNO-9755511; KEAP1-NFE2L2 pathway.
DR   PRO; PR:F1M7Y5; -.
DR   Proteomes; UP000002494; Chromosome 2.
DR   Bgee; ENSRNOG00000009652; Expressed in stomach and 20 other cell types or tissues.
DR   GO; GO:0045177; C:apical part of cell; ISO:RGD.
DR   GO; GO:0016324; C:apical plasma membrane; ISO:RGD.
DR   GO; GO:0005923; C:bicellular tight junction; IDA:RGD.
DR   GO; GO:0005903; C:brush border; ISO:RGD.
DR   GO; GO:0031252; C:cell leading edge; IDA:RGD.
DR   GO; GO:0005737; C:cytoplasm; ISO:RGD.
DR   GO; GO:0005829; C:cytosol; ISS:UniProtKB.
DR   GO; GO:0005768; C:endosome; IEA:UniProtKB-SubCell.
DR   GO; GO:0098978; C:glutamatergic synapse; IDA:SynGO.
DR   GO; GO:0000139; C:Golgi membrane; IEA:GOC.
DR   GO; GO:0045171; C:intercellular bridge; IEA:Ensembl.
DR   GO; GO:0015630; C:microtubule cytoskeleton; IEA:Ensembl.
DR   GO; GO:0005634; C:nucleus; ISS:UniProtKB.
DR   GO; GO:0120157; C:PAR polarity complex; ISO:RGD.
DR   GO; GO:0098685; C:Schaffer collateral - CA1 synapse; IDA:SynGO.
DR   GO; GO:0043220; C:Schmidt-Lanterman incisure; ISO:RGD.
DR   GO; GO:0005524; F:ATP binding; IEA:UniProtKB-KW.
DR   GO; GO:0004697; F:diacylglycerol-dependent serine/threonine kinase activity; ISO:RGD.
DR   GO; GO:0046872; F:metal ion binding; IEA:UniProtKB-KW.
DR   GO; GO:0005543; F:phospholipid binding; ISO:RGD.
DR   GO; GO:0004672; F:protein kinase activity; ISS:UniProtKB.
DR   GO; GO:0106310; F:protein serine kinase activity; IEA:RHEA.
DR   GO; GO:0004674; F:protein serine/threonine kinase activity; ISO:RGD.
DR   GO; GO:0007015; P:actin filament organization; ISO:RGD.
DR   GO; GO:0016477; P:cell migration; IMP:RGD.
DR   GO; GO:0045216; P:cell-cell junction organization; ISO:RGD.
DR   GO; GO:0032869; P:cellular response to insulin stimulus; IMP:RGD.
DR   GO; GO:0035089; P:establishment of apical/basal cell polarity; ISO:RGD.
DR   GO; GO:0045197; P:establishment or maintenance of epithelial cell apical/basal polarity; ISO:RGD.
DR   GO; GO:0042462; P:eye photoreceptor cell development; ISO:RGD.
DR   GO; GO:0048194; P:Golgi vesicle budding; IDA:RGD.
DR   GO; GO:0035556; P:intracellular signal transduction; IBA:GO_Central.
DR   GO; GO:0034351; P:negative regulation of glial cell apoptotic process; ISS:UniProtKB.
DR   GO; GO:0043524; P:negative regulation of neuron apoptotic process; ISS:UniProtKB.
DR   GO; GO:2000353; P:positive regulation of endothelial cell apoptotic process; ISS:UniProtKB.
DR   GO; GO:0060252; P:positive regulation of glial cell proliferation; ISS:UniProtKB.
DR   GO; GO:0046326; P:positive regulation of glucose import; ISO:RGD.
DR   GO; GO:0010976; P:positive regulation of neuron projection development; ISS:UniProtKB.
DR   GO; GO:0051092; P:positive regulation of NF-kappaB transcription factor activity; ISS:UniProtKB.
DR   GO; GO:1903078; P:positive regulation of protein localization to plasma membrane; ISO:RGD.
DR   GO; GO:0099072; P:regulation of postsynaptic membrane neurotransmitter receptor levels; IDA:SynGO.
DR   GO; GO:0070555; P:response to interleukin-1; IMP:RGD.
DR   GO; GO:0043434; P:response to peptide hormone; IDA:RGD.
DR   CDD; cd20794; C1_aPKC; 1.
DR   CDD; cd06404; PB1_aPKC; 1.
DR   CDD; cd05618; STKc_aPKC_iota; 1.
DR   Gene3D; 3.30.60.20; -; 1.
DR   Gene3D; 1.10.510.10; Transferase(Phosphotransferase) domain 1; 1.
DR   InterPro; IPR000961; AGC-kinase_C.
DR   InterPro; IPR034661; aPKC_iota.
DR   InterPro; IPR046349; C1-like_sf.
DR   InterPro; IPR020454; DAG/PE-bd.
DR   InterPro; IPR011009; Kinase-like_dom_sf.
DR   InterPro; IPR053793; PB1-like.
DR   InterPro; IPR034877; PB1_aPKC.
DR   InterPro; IPR000270; PB1_dom.
DR   InterPro; IPR002219; PE/DAG-bd.
DR   InterPro; IPR012233; PKC.
DR   InterPro; IPR017892; Pkinase_C.
DR   InterPro; IPR000719; Prot_kinase_dom.
DR   InterPro; IPR017441; Protein_kinase_ATP_BS.
DR   InterPro; IPR008271; Ser/Thr_kinase_AS.
DR   PANTHER; PTHR24351:SF236; PROTEIN KINASE C IOTA TYPE; 1.
DR   PANTHER; PTHR24351; RIBOSOMAL PROTEIN S6 KINASE; 1.
DR   Pfam; PF00130; C1_1; 1.
DR   Pfam; PF00564; PB1; 1.
DR   Pfam; PF00069; Pkinase; 1.
DR   Pfam; PF00433; Pkinase_C; 1.
DR   PIRSF; PIRSF000554; PKC_zeta; 1.
DR   PRINTS; PR00008; DAGPEDOMAIN.
DR   SMART; SM00109; C1; 1.
DR   SMART; SM00666; PB1; 1.
DR   SMART; SM00133; S_TK_X; 1.
DR   SMART; SM00220; S_TKc; 1.
DR   SUPFAM; SSF54277; CAD & PB1 domains; 1.
DR   SUPFAM; SSF57889; Cysteine-rich domain; 1.
DR   SUPFAM; SSF56112; Protein kinase-like (PK-like); 1.
DR   PROSITE; PS51285; AGC_KINASE_CTER; 1.
DR   PROSITE; PS51745; PB1; 1.
DR   PROSITE; PS00107; PROTEIN_KINASE_ATP; 1.
DR   PROSITE; PS50011; PROTEIN_KINASE_DOM; 1.
DR   PROSITE; PS00108; PROTEIN_KINASE_ST; 1.
DR   PROSITE; PS00479; ZF_DAG_PE_1; 1.
DR   PROSITE; PS50081; ZF_DAG_PE_2; 1.
PE   1: Evidence at protein level;
KW   Acetylation; ATP-binding; Cytoplasm; Developmental protein; Endosome;
KW   Kinase; Membrane; Metal-binding; Nucleotide-binding; Nucleus;
KW   Phosphoprotein; Proto-oncogene; Reference proteome;
KW   Serine/threonine-protein kinase; Transferase; Tumor suppressor; Zinc;
KW   Zinc-finger.
FT   INIT_MET        1
FT                   /note="Removed"
FT                   /evidence="ECO:0000250|UniProtKB:P41743"
FT   CHAIN           2..596
FT                   /note="Protein kinase C iota type"
FT                   /id="PRO_0000414090"
FT   DOMAIN          25..108
FT                   /note="PB1"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU01081"
FT   DOMAIN          254..522
FT                   /note="Protein kinase"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00159"
FT   DOMAIN          523..594
FT                   /note="AGC-kinase C-terminal"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00618"
FT   ZN_FING         140..190
FT                   /note="Phorbol-ester/DAG-type"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00226"
FT   REGION          1..21
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   REGION          2..253
FT                   /note="Regulatory domain"
FT                   /evidence="ECO:0000250"
FT   REGION          2..28
FT                   /note="Required for interaction with RAB2"
FT                   /evidence="ECO:0000250"
FT   REGION          72..91
FT                   /note="Interaction with PARD6A"
FT                   /evidence="ECO:0000250"
FT   MOTIF           125..134
FT                   /note="Pseudosubstrate"
FT                   /evidence="ECO:0000250"
FT   ACT_SITE        378
FT                   /note="Proton acceptor"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00159,
FT                   ECO:0000255|PROSITE-ProRule:PRU10027"
FT   BINDING         260..268
FT                   /ligand="ATP"
FT                   /ligand_id="ChEBI:CHEBI:30616"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00159"
FT   BINDING         283
FT                   /ligand="ATP"
FT                   /ligand_id="ChEBI:CHEBI:30616"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00159"
FT   MOD_RES         2
FT                   /note="N-acetylproline"
FT                   /evidence="ECO:0000250|UniProtKB:P41743"
FT   MOD_RES         3
FT                   /note="Phosphothreonine"
FT                   /evidence="ECO:0000250|UniProtKB:P41743"
FT   MOD_RES         7
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000250|UniProtKB:P41743"
FT   MOD_RES         8
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000250|UniProtKB:P41743"
FT   MOD_RES         9
FT                   /note="Phosphothreonine"
FT                   /evidence="ECO:0000250|UniProtKB:P41743"
FT   MOD_RES         265
FT                   /note="Phosphotyrosine; by SRC"
FT                   /evidence="ECO:0000269|PubMed:11891849"
FT   MOD_RES         280
FT                   /note="Phosphotyrosine; by SRC"
FT                   /evidence="ECO:0000250|UniProtKB:P41743"
FT   MOD_RES         334
FT                   /note="Phosphotyrosine; by SRC"
FT                   /evidence="ECO:0000250|UniProtKB:P41743"
FT   MOD_RES         412
FT                   /note="Phosphothreonine; by PDPK1"
FT                   /evidence="ECO:0000250|UniProtKB:P41743"
FT   MOD_RES         564
FT                   /note="Phosphothreonine"
FT                   /evidence="ECO:0000269|PubMed:27498875,
FT                   ECO:0007744|PubMed:22673903"
FT   MUTAGEN         265
FT                   /note="Y->F: Loss of phosphorylation and nuclear import."
FT                   /evidence="ECO:0000269|PubMed:11891849"
FT   CONFLICT        171
FT                   /note="C -> R (in Ref. 2; ACA66272)"
FT                   /evidence="ECO:0000305"
SQ   SEQUENCE   596 AA;  68276 MW;  60035F56E7547C57 CRC64;
     MPTQRDSSTM SHTVACGGGG DHSHQVRVKA YYRGDIMITH FEPSISFEGL CSEVRDMCSF
     DNEQPFTMKW IDEEGDPCTV SSQLELEEAF RLYELNKDSE LLIHVFPCVP ERPGMPCPGE
     DKSIYRRGAR RWRKLYCANG HTFQAKRFNR RAHCAICTDR IWGLGRQGYK CINCKLLVHK
     KCHKLVTIEC GRHSLPPEPM MPMDQSSMHP DHTQTVIPYN PSSHESLDQV GEEKEAMNTR
     ESGKASSSLG LQDFDLLRVI GRGSYAKVLL VRLKKTDRIY AMKVVKKELV NDDEDIDWVQ
     TEKHVFEQAS NHPFLVGLHS CFQTESRLFF VIEYVNGGDL MFHMQRQRKL PEEHARFYSA
     EISLALNYLH ERGIIYRDLK LDNVLLDSEG HIKLTDYGMC KEGLRPGDTT STFCGTPNYI
     APEILRGEDY GFSVDWWALG VLMFEMMAGR SPFDIVGSSD NPDQNTEDYL FQVILEKQIR
     IPRSLSVKAA SVLKSFLNKD PKERLGCHPQ TGFADIQGHP FFRNVDWDMM EQKQVVPPFK
     PNISGEFGLD NFDSQFTNEP VQLTPDDDDI VRKIDQSEFE GFEYINPLLM SAEECV
//
